About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01180023

Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients

Sweeping or stripping of the membranes (in this paper referred to as "membrane sweeping") is a widely utilized technique to hasten delivery for women at 37+ weeks gestation. The process of membrane sw...

Lead sponsor: George Washington University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

George Washington University

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•All women presenting to the Medical Faculty Associates outpatient Obstetrics clinic who are 37+ weeks
•Are at least 18 years of age and can read and write in English
•Are candidates for vaginal delivery, and qualify for GBS prophylaxis by CDC criteria (any one of the following:
•* have rectovaginal cultures positive for GBS
•* have a GBS UTI this pregnancy
•* have had an infant with GBS disease in a prior delivery) will be offered enrollment in the study.

Exclusion Criteria

•Patients who are not candidates for vaginal delivery (placenta previa, breech presentation, planned repeat cesarean), will be excluded from the study.
•Patients who are HIV positive will also be excluded, since membrane sweeping may have some risks in these patients.

Related studies

Preparing for Maternal GBS Vaccine Trials in Africa

NCT06833957 · Group B Streptococcus, Invasive Bacterial Diseases (IBD), and more

A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers

NCT06280157 · Group B Streptococcus Infection

COMPLETEDPhase 2

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women

NCT04766086 · Group B Streptococcus Infections

The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

NCT01251289 · Group B Streptococcus

COMPLETEDPhase 1

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women

NCT01150123 · Group B Streptococcus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 15, 2013Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment120

Start dateApr 2008

Last updatedFeb 15, 2013

Condition

Group B Streptococcus

Locations shown

Medical Faculty Associates

Washington D.C., District of Columbia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 15, 2013Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions